Trial Details
COMPLETEDBasic Information
| Clinical ID | c3817 |
|---|---|
| Identifier | NCT01489943 |
| Trial Title | A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: GSK1605786 500 mg|DRUG: Midazolam 3 mg|DRUG: Pioglitazone 15 mg|DRUG: Omeprazole 40 mg|DRUG: Rosuvastatin 10 mg |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Buffalo |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2011-09-19 |
|---|---|
| Primary Completion Date | 2011-11-10 |
| Completion Date | 2011-11-10 |